Problem Suspected acute MI
Format -
Treatment Alteplase OR Reteplase
Control Streptokinase
Population 15059 patients with MI symptoms between 30min and 6 hours
Inclusion criteria -
Exclusion criteria -
Follow-up 30 days and 1 year
Primary endpoint All cause mortality
Secondary endpoint(s) -
Details .
Brief summary:
PAPER: Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded...
Date 10 Oct 2000
Journal Circulation. 2000 Oct 10;102(15):1761-5.
Information -No significant difference in mortality between reteplase and alteplase at 30 days and 1 year